Copyright
©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 112796
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.112796
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.112796
Table 1 Characteristics of the included case reports and case series
| Ref. | Study type | Patient’s age/gender | Comorbidities | Clinical features | Serum creatinine (mg/dL) | Renal sonography | Renal biopsy | Treatment | Outcome | Hair straightening method |
| Abu-Amer et al[20], 2022 | Case report | 41/F | Hypothyroidism, sleeve gastrectomy | Weakness, nausea, vomiting | 3.46 | Yes | Yes | Prednisolone 1 mg/kg | Recovered. creatinine 0.9 after one week | Formaldehyde-free product |
| Bashir and Khater[16], 2023 | Case report | 40/F | Hypothyroidism | Scalp rash, hypertension, hyperkalemia | 3.5 | No | Yes | Pulse steroids | Recovered. Creatinine 0.9 at 4-month follow-up | Formaldehyde-free product |
| Huber et al[15], 2024 | Case report | 42/F | Healthy | Weakness, nausea, vomiting, flank pain, diarrhea, flank tenderness, hypertension | 6.61 | Yes | Yes | Conservative management | Recovered. Creatinine 0.87 at 3-month follow-up | Unknown |
| Mitler et al[18], 2021 | Case report | 13/F | Healthy | Abdominal pain, nausea, vomiting, oliguria, tachycardia, hypertension, dehydration, abdominal tenderness | 3.56 | Yes | Yes | Hemodialysis for four consecutive days | Recovered. Creatinine normalized 6-month follow-up | Formaldehyde-free product |
| Robert et al[41], 2024 | Case report incidence 1 | 26/F | Healthy | Scalp burning sensation, scalp ulcers, vomiting, diarrhea, fever, back pain | 2.1 | Yes | No | Unknown | Recovered. Serum creatinine returned to normal (0.78) at the last follow-up | Containing 10% glyoxylic acid but no glycolic acid |
| Incidence 2 | 25/F | Scalp burning sensation, scalp ulcers, vomiting, diarrhea, fever, back pain | 2.4 | Yes | No | Unknown | Recovered. Serum creatinine returned to normal (0.78) at the last follow-up | Formaldehyde-free product (containing 10% glyoxylic acid but no glycolic acid) | ||
| Incidence 3 | 24/F | Scalp burning sensation, scalp ulcers, vomiting, diarrhea, fever, back pain | 1.9 | Yes | No | Unknown | Recovered. Serum creatinine returned to normal (0.78) at the last follow-up | Formaldehyde-free product (containing 10% glyoxylic acid but no glycolic acid) | ||
| Zergui et al[14], 2025 | Case report | 25/F | Nausea, vomiting, weakness | 3.2 | Yes | No | Saline, calcium gluconate, insulin, 25 g glucose, sodium bicarbonate | Recovered. Serum creatinine returned to 1.2 at the two-week follow-up | Formaldehyde-free product (contained glyoxylic acid) | |
| Ahmed et al[17], 2019 | Case series of 2 cases case 1 | 10/F | Healthy | Vomiting, tachycardia, dyspnea, hypertension, scalp rash | 13.2 | Yes | Yes | Hemodialysis for three consecutive days; 20 mg/kg/dose methylprednisolone for three days followed by oral prednisone (60 mg/m2/day) | Recovered. Discharged with improved RFTs | Formaldehyde-free product |
| Case 2 | 17/F | Healthy | Vomiting, syncope, scalp rash | 9.9 | Yes | Yes | Hemodialysis for three consecutive days; corticosteroids 40 mg/day | Recovered. Discharged with normal RFTs | Formaldehyde-free product | |
| Bnaya et al[19], 20231 | Case series of 26 cases case 1 | 24/F | Healthy | Abdominal pain, nausea | 5.82 | No | No | No KRT, no steroids | Recovered | Unknown |
| Case 2 | 22/F | Healthy | Abdominal pain, nausea, vomiting, scalp rash | 2.76 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 3 | 30/F | Nephrolithiasis | Nausea, vomiting, scalp rash, flank pain | 4.81 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 4 | 29/F | Healthy | Nausea, vomiting, scalp rash | 2.09 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 5 | 21/F | Epilepsy | Abdominal pain, vomiting, scalp rash, headache | 11.83 | No | Yes | Steroids | Recovered | Unknown | |
| Case 6 | 58/F | Healthy | Nausea, flank pain, syncope | 7.54 | No | Yes | Steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 7 | 14/F | Healthy | Nausea, flank pain, headache | 3.8 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 8 | 31/F | Healthy, smoking | Abdominal pain, vomiting, diarrhea | 8.14 | No | No | Temporary hemodialysis | Recovered | Unknown | |
| Case 9 | 29/F | Nephrolithiasis | Vomiting, scalp rash | 6.8 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 10 | 52/F | Psoriasis, nephrolithiasis | Abdominal pain, flank pain, nausea, vomiting | 3.4 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 11 | 24/F | Healthy | Abdominal pain, nausea, fever | 2.17 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 12 | 33/F | Healthy | Nausea, vomiting, chills | 6 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 13 | 13/F | Healthy | Abdominal pain, nausea, vomiting | 3.56 | No | Yes | Temporary hemodialysis | Recovered | Unknown | |
| Case 14 | 17/F | Psoriasis | Abdominal pain, nausea, vomiting | 7.1 | No | Yes | Temporary hemodialysis and steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 15 | 17.5/F | Healthy | Abdominal pain, nausea, vomiting, fever, scalp rash | 2.9 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 16 | 24/F | Healthy | Abdominal pain, nausea, vomiting, scalp rash | 4.2 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 17 | 36/F | Healthy | Nausea, vomiting, scalp rash | 6 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 18 | 21/F | Healthy | Abdominal pain, nausea, vomiting | 3.2 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 19 | 41/F | Hypothyroidism, sleeve gastrectomy | Nausea, vomiting | 3.46 | No | Yes | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 20 | 19/F | Healthy | Nausea, flank pain, headache | 5.09 | No | Yes | Steroids | Recovered | Unknown | |
| Case 21 | 44/F | Hypercoagulability state (prothrombin variant) | Vomiting, flank pain | 7.8 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 22 | 50/F | Healthy | Nausea, vomiting | 7.3 | No | No | No KRT, no steroids | Recovered | Unknown | |
| Case 23 | 21/F | Healthy | Nausea, vomiting, flank pain, scalp rash | 3.68 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 24 | 28/F | Atopic dermatitis, gastroesophageal reflux disease | Nausea, vomiting, flank pain, scalp rash | 2.83 | No | No | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 25 | 32/F | Healthy | Abdominal pain, nausea, vomiting | 9.03 | No | Yes | No KRT, no steroids | Recovered | Formaldehyde-free product (containing glycolic acid) | |
| Case 26 | 30/F | Healthy | Flank pain | 7.36 | No | No | No KRT, no steroids | Recovered | Unknown |
Table 2 Renal ultrasonography findings of included studies
| Ref. | Sonography findings |
| Abu-Amer et al[20], 2022 | 14.4-cm bilateral echogenic, edematous renal parenchyma |
| Huber et al[15], 2024 | Normal kidneys with slight corticomedullary dedifferentiation, absence of pyelocaliceal dilation, and normal vascular flow |
| Mitler et al[18], 2021 | 15-cm edematous renal parenchyma |
| Robert et al[41], 2024 (3 incidents in the same patient) | No evidence of obstructive uropathy |
| Zergui et al[14], 2025 | Normal-sized kidneys; findings consistent with acute kidney injury of non-obstructive etiology |
| Ahmed et al[17], 2019 (case 1) | Bilateral grade 1 nephropathy |
| Ahmed et al[17], 2019 (case 2) | Bilateral grade 1 nephropathy |
Table 3 Renal biopsy findings of included studies
| Ref. | Microscopic findings |
| Abu-Amer et al[20], 2022 | The biopsy demonstrated features of both oxalate nephropathy and interstitial nephritis (intratubular oxalate crystals, interstitial edema, mixed inflammatory infiltrates with eosinophils, and foci of tubulitis) |
| Bashir and Khater[16], 2023 | Acute interstitial nephritis |
| Huber et al[15], 2024 | Findings were consistent with oxalate nephropathy rather than interstitial nephritis (numerous intratubular calcium oxalate crystal deposits and mild interstitial edema without inflammatory infiltrates) |
| Mitler et al[18], 2021 | Oxalate nephropathy (microcalcifications/calcium oxalate crystals) |
| Ahmed et al[17], 2019 (case 1) | Acute tubulointerstitial nephritis |
| Ahmed et al[17], 2019 (case 2) | Acute tubulointerstitial nephritis |
| Bnaya et al[19], 2023 (case 5) | The biopsy demonstrated features of both oxalate nephropathy and interstitial nephritis (calcium oxalate crystals, small mononuclear interstitial infiltrate with spare eosinophils) |
| Bnaya et al[19], 2023 (case 6) | The biopsy demonstrated features of both oxalate nephropathy and interstitial nephritis (oxalate crystals, small mononuclear interstitial infiltrate) |
| Bnaya et al[19], 2023 (case 13) | The biopsy demonstrated oxalate nephropathy (microcalcifications/calcium oxalate crystals) |
| Bnaya et al[19], 2023 (case 14) | Oxalate nephropathy |
| Bnaya et al[19], 2023 (case 19) | The biopsy demonstrated features of both oxalate nephropathy and interstitial nephritis (oxalate crystals, multifocal mixed inflammatory infiltrates with multiple eosinophils) |
| Bnaya et al[19], 2023 (case 20) | Findings were consistent with oxalate nephropathy rather than interstitial nephritis (calcium oxalate crystals; interstitium with mild edema and sparse eosinophils) |
| Bnaya et al[19], 2023 (case 25) | Oxalate nephropathy |
Table 4 Quality of the included case reports and case series
| Ref. | Was the exposure (hair-straightening products) adequately ascertained?1 | Was the outcome (AKI) adequately ascertained?2 | Were other alternative causes that may explain the outcome (AKI) ruled out?3 | Were all important data cited?4 | Risk of bias5 |
| Abu-Amer et al[20], 2022 | Yes | Yes | Yes | Yes | Low |
| Bashir and Khater[16], 2023 | Yes | Yes | Yes | Yes | Low |
| Huber et al[15], 2024 | Yes | Yes | Yes | Yes | Low |
| Mitler et al[18], 2021 | Yes | Yes | Yes | Yes | Low |
| Robert et al[41], 2024 | Yes | Yes | Yes | Yes | Low |
| Zergui et al[14], 2025 | Yes | Yes | Yes | Yes | Low |
| Ahmed et al[17], 2019 | Yes | Yes | Yes | Yes | Low |
| Bnaya et al[19], 2023 | Yes | Yes | Yes | Yes | Low |
- Citation: Aamir AB, Latif R, Sorath F, Chander S, Latif A, Rahaman Z, Mohammed YN, Parkash O, Devi P, Hassan GA, Alalwan BM. Acute kidney injury induced by topical hair straightening products: A systematic review. World J Nephrol 2025; 14(4): 112796
- URL: https://www.wjgnet.com/2220-6124/full/v14/i4/112796.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i4.112796
